(Q44132707)

English

Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models

scientific article published in October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

vector-borne disease

0 references

1 reference

based on heuristic

inferred from title

author name string

Masaaki Mizuno

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Yasushi Ryuke

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Jun Yoshida

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

825-829

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700503

0 references

Transduction efficiency of adenoviral vectors into human glioma cells increased by association with cationic liposomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700503

21 January 2018

Cationic liposome conjugation to recombinant adenoviral vector reduces viral antigenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700503

21 January 2018

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700503

21 January 2018

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700503

21 January 2018

Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700503

21 January 2018

Adenovirus-assisted lipofection: efficient in vitro gene transfer of luciferase and cytosine deaminase to human smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700503

21 January 2018

Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700503

21 January 2018

Efficacy of repeated adenoviral suicide gene therapy in a localized murine tumor model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700503

21 January 2018

Identifiers

10.1038/SJ.CGT.7700503

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44132707&oldid=2106934579"